Navigation Links
Launch of second European Cancer Research Funding survey
Date:9/18/2007

Brussels: The second European survey [1] analysing how cancer research is funded shows that contrary to public perception Europe is a major contributor to the global cancer research effort.

Prof Richard Sullivan, chair of the European Cancer Research Managers Forum (ECRM), launched the organisations second survey, which looks at the overall 3.2 billion cancer research spend for 2004, at the European Parliament today (Tuesday 18 September).

Contrary to public perception, a phenomenal amount of cancer research is carried out in Europe, evidenced by the huge amount of cancer research papers being published here, said Prof Sullivan. This is important, as many policy makers assume the global funding for cancer research is overwhelmingly concentrated in the USA. Our data indicate that this is not true and the effort is a truly global one. The possibilities for fruitful partnerships not only exist, but should be the basis for future long-term policy. We should not fail next generations in losing this opportunity.

He stressed that with over 100 major funders in both Europe and the USA, who each spend more than 1 million a year on cancer research, as well as a number of important representational bodies, there has never been such a golden opportunity for a more co-operative approach in the field, particularly towards the funding of trans-national research programmes.

Prof Sullivan added that whilst global levels of cancer research expenditure on cancer research as a percentage of GDP continue to show differences between the USA and Europe, this gap has substantially narrowed.

A major part of this survey has been its ability to estimate the cancer research funding flowing through national healthcare and university systems in Europe, but there has also been a real increase in some Member State funding whilst the USA shrinks in real terms.

However Prof Sullivan made an urgent plea for less bureaucracy which he s
'/>"/>

Contact: Josie Bate
josie@bateonline.co.uk
44-079-711-01404
European Cancer Research Managers Forum
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Glaxo launches pills to help smokers quit in 7-12 weeks
3. Action Plan Against Drug Deaths Launched
4. New Health Scheme Launched In India’s Biha
5. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
6. Dr Reddy’s Laboratories launches Hyalosy
7. Sun Pharma to launch chiral version of omeprazole soon
8. Asmanex Twisthaler launched by Schering-Plough for treatment of asthma
9. New initiative launched to fight malaria by repelling mosquitoes
10. Clarithromycin tablets to be launched in India soon
11. Guide for physicians launched to help them identify alcohol disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 19, 2014 Slone ... diagnostic, personalized medicine, healthcare information technology, and laboratory ... position of Chief Operating Officer. The announcement comes ... marked by a strengthened presence in Boston and ... "Leslie lives and breathes the client experience," said ...
(Date:12/19/2014)... THURSDAY, Dec. 18, 2014 (HealthDay News) -- Being in good ... researchers report. They looked at data from more than ... who underwent treadmill tests between 1991 and 2009. Those ... chance of having high blood pressure at the start of ... with high levels of fitness. Of the more than ...
(Date:12/19/2014)... -- Traveling through the same U.S. airport gate, one ... within a four-hour time span, illustrating just how easily ... "The exposures in this report were not prolonged and ... highlighting the fact that measles is highly contagious," wrote ... specialist at the U.S. Centers for Disease Control and ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Unidesk ... Osteopathic Medicine (ACOM), which welcomed its inaugural class ... Infrastructure (VDI) to seamlessly support bring your own ... and teaching – experience. The solution, comprised of ... , Dell server and storage infrastructure ...
(Date:12/17/2014)... Miami, FL (PRWEB) December 17, 2014 ... has not been able to eradicate the head louse ... and hassle for parents. Each year between six and ... Lice Troopers, the Miami-based lice removal treatment company comes ... safe, non-toxic and environmentally friendly. With its track record ...
Breaking Medicine News(10 mins):Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2
... 28 Dr. Eaton E.,Lattman, currently Dean of Research ... and Sciences at Johns Hopkins University (JHU), has,been appointed ... Research Institute. Lattman will assume the,position on July 1, ... has degrees from Harvard and JHU and at JHU ...
... medications longer, study finds , , FRIDAY, March 28 (HealthDay ... than the older drug haloperidol in treating a first ... it appears that more patients prefer the newer drugs ... haloperidol, the study authors said. , "When we compared ...
... Raleigh County League of,Democratic Women will conduct a mock ... Clinton and Barack Obama., "We,re not expecting the ... each one will be represented by two local,volunteers supporting ... be held at 6 p.m. Tuesday at the Raleigh ...
... using whole body 16 multi-detector CT (MDCT); theres no need ... recent study conducted by researchers at the University of Maryland ... in Baltimore, MD. The study showed that whole body MDCT ... In the past, blunt trauma patients would undergo whole-body MDCT ...
... from Boston University School of Medicine (BUSM) and ... found that decreased sexual satisfaction in postmenopausal women, ... study appears in the April 2008 issue of ... dysfunction is a common condition and has been ...
... to try technology like sensors,to detect falls and ... perception, and technical issues remain challenges, WASHINGTON, ... so they can age safely in their home. ... the challenges of caregiving.,Concerns such as cost to ...
Cached Medicine News:Health News:Hauptman-Woodward Appoints Dr. Eaton Lattman CEO and Executive Director 2Health News:Hauptman-Woodward Appoints Dr. Eaton Lattman CEO and Executive Director 3Health News:New Drugs No Better Than Older Ones for Schizophrenia 2Health News:New Drugs No Better Than Older Ones for Schizophrenia 3Health News:Whole body MDCT just as 'good' as neck MDCT angiography in diagnosing head and neck injuries 2Health News:Decreased sexual satisfaction is not associated with cardiovascular disease in postmenopausal women 2Health News:Older People Want to Use Technology to Help Them Remain at Home 2Health News:Older People Want to Use Technology to Help Them Remain at Home 3Health News:Older People Want to Use Technology to Help Them Remain at Home 4
(Date:12/17/2014)... 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: ... Office (USPTO) has issued a key patent covering ... vaccine targeting six tumor antigens that are commonly ... No. 8,871,211, which issued October 28, 2014, include ... dendritic cell composition comprising peptide epitopes of the ...
(Date:12/15/2014)... December 15, 2014 ... 19. und 20. Februar sind alle akkreditierten ... MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ 2015 in ... Diese Tagung soll dazu beitragen, ... geben, die neue profitablen Unternehmensdienstleistungen, die für ...
(Date:12/15/2014)... December 15, 2014 BerGenBio AS, ... aggressive drug resistant cancers, today announces that it has ... placing from new and existing investors. BerGenBio ... the development of its pipeline of innovative cancer therapeutics, ... lead drug candidate, BGB324, a first-in-class selective Axl kinase ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2BerGenBio Completes NOK90 Million Fundraising 2
... DIEGO, March 10, 2011 Orexigen® Therapeutics, Inc. (Nasdaq: ... today announced financial results for the three months and year ended ... 31, 2010 For the three months ended December ... $0.24 per share, as compared to a net loss of $15.0 ...
... 2011 Dendreon Corporation (Nasdaq: DNDN ) ... (FDA) approved the remainder of its New Jersey manufacturing ... of PROVENGE® (sipuleucel-T) to help meet the needs of ... (hormone refractory) prostate cancer.   Last April, ...
Cached Medicine Technology:Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results 2Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results 3Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results 4Dendreon Expands Launch of PROVENGE 2Dendreon Expands Launch of PROVENGE 3Dendreon Expands Launch of PROVENGE 4Dendreon Expands Launch of PROVENGE 5
Indications For Usage: , When patient's head is in an extended or flexed position When patient will be turned over. , Long-term cases where maintenance of an airway is critical. , Neurosurgical pr...
Indications For Usage: , Airway management during surgical procedures , Long-term ventilatory management ...
... The Thermal Angel® is an in-line, ... and IV fluid warming device, capable of ... Thermal Angel® can be used to help ... TA-200 will strive to achieve 38°C (100.4°F) ...
... is the only effective solution for ... surgical irrigation, especially urologic procedures. Patients ... of length of procedure or irrigant ... performance and is easy to set ...
Medicine Products: